# The Efficacy of Intralesional Bleomycin as Compared to 5-Flourouracil (5-FU) and Triamcinolone Acetonide (TAC) for the Treatment of Keloids: A Randomized Control Trial.

> **NCT07201766** · NA · NOT_YET_RECRUITING · sponsor: **King Edward Medical University** · enrollment: 104 (estimated)

## Conditions studied

- Keloids Scars

## Interventions

- **DRUG:** intralesional bleomycin
- **DRUG:** 5-flourouracil and triamcinolone acetonide

## Key facts

- **NCT ID:** NCT07201766
- **Lead sponsor:** King Edward Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-02
- **Primary completion:** 2026-02-20
- **Final completion:** 2026-02-28
- **Target enrollment:** 104 (ESTIMATED)
- **Last updated:** 2025-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07201766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07201766, "The Efficacy of Intralesional Bleomycin as Compared to 5-Flourouracil (5-FU) and Triamcinolone Acetonide (TAC) for the Treatment of Keloids: A Randomized Control Trial.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07201766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*